On the public citation graph
Virtual Screening to Successfully Identify Novel Janus Kinase 3 Inhibitors: A Sequential Focused Screening Approach
0 signed · 44 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.bmcl.2006.10.062openalex-snapshot
Simplified staurosporine analogs as potent JAK3 inhibitors
inferredcites →https://doi.org/10.1016/s0166-3542(01)00222-4openalex-snapshot
Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening
inferredcites →https://doi.org/10.1016/s0960-894x(00)00051-2openalex-snapshot
Naphthyl ketones: a new class of Janus kinase 3 inhibitors
inferredcites →https://doi.org/10.1016/s0960-894x(02)00106-3openalex-snapshot
Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor
inferredcites →https://doi.org/10.1016/s0960-894x(03)00480-3openalex-snapshot
High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate
inferredcites →https://doi.org/10.1016/s0960-894x(03)00631-0openalex-snapshot
Pyrazolo[4,3-d]pyrimidines as new generation of cyclin-dependent kinase inhibitors
inferredcites →https://doi.org/10.1016/s1056-8719(00)00073-3openalex-snapshot
Use of recursive partitioning in the sequential screening of G-protein–coupled receptors
inferredcites →https://doi.org/10.1021/jm040099aopenalex-snapshot
Synthesis and Discovery of Pyrazine−Pyridine Biheteroaryl as a Novel Series of Potent Vascular Endothelial Growth Factor Receptor-2 Inhibitors
inferredcites →https://doi.org/10.1021/jm970124vopenalex-snapshot
Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines
inferredcites →https://doi.org/10.1038/nbt1068openalex-snapshot
A small molecule–kinase interaction map for clinical kinase inhibitors
inferredcites →https://doi.org/10.1038/nrd1063openalex-snapshot
Designing screens: how to make your hits a hit
inferredcites →https://doi.org/10.1038/nrd941openalex-snapshot
Integration of virtual and high-throughput screening
inferredcites →https://doi.org/10.1038/sj.onc.1203925openalex-snapshot
Janus kinases: components of multiple signaling pathways
inferredcites →https://doi.org/10.1042/bj20021535openalex-snapshot
The specificities of protein kinase inhibitors: an update
inferredcites →https://doi.org/10.1073/pnas.251194298openalex-snapshot
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
inferredcites →https://doi.org/10.1074/jbc.274.38.27028openalex-snapshot
Targeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis
inferredcites →https://doi.org/10.1074/jbc.m207135200openalex-snapshot
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
inferredcites →https://doi.org/10.1126/science.1077002openalex-snapshot
A Critical Role for IL-21 in Regulating Immunoglobulin Production
inferredcites →https://doi.org/10.1126/science.1087061openalex-snapshot
Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
inferredcites →https://doi.org/10.1177/108705710100600303openalex-snapshot
High Throughput Screening: Early Successes Indicate a Promising Future
inferredcites →https://doi.org/10.1201/9781420028775openalex-snapshot
Virtual Screening in Drug Discovery
inferredcites →https://doi.org/10.1358/dnp.2005.18.5.904198openalex-snapshot
JAK Protein Kinase Inhibitors
inferredcites →https://doi.org/10.1517/14728222.8.6.613openalex-snapshot
Janus kinase 3: a novel target for selective transplant immunosupression
inferredcites →https://doi.org/10.2174/138620706775541882openalex-snapshot
Comparison of Methods for Sequential Screening of Large Compound Sets
inferredcites →https://doi.org/10.4049/jimmunol.155.11.5220openalex-snapshot
Regulation of JAK3 expression and activation in human B cells and B cell malignancies
inferredcites →https://doi.org/10.4049/jimmunol.162.7.3897openalex-snapshot
JAK3, STAT, and MAPK Signaling Pathways as Novel Molecular Targets for the Tyrphostin AG-490 Regulation of IL-2-Mediated T Cell Response
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9780470584170.ch2openalex-snapshot
High Throughput Screening Approach to Lead Discovery
inferred← citeshttps://doi.org/10.1002/9783527633326.ch12openalex-snapshot
Applications and Success Stories in Virtual Screening
inferred← citeshttps://doi.org/10.1002/9783527677047.ch05openalex-snapshot
Lead Generation Based on Compound Collection Screening
inferred← citeshttps://doi.org/10.1007/s10822-010-9321-0openalex-snapshot
Consensus model for identification of novel PI3K inhibitors in large chemical library
inferred← citeshttps://doi.org/10.1016/b978-0-444-62652-3.00004-1openalex-snapshot
Advances in the Discovery of Selective JAK Inhibitors
inferred← citeshttps://doi.org/10.1016/j.jim.2010.01.010openalex-snapshot
A receptor-independent, cell-based JAK activation assay for screening for JAK3-specific inhibitors
inferred← citeshttps://doi.org/10.1016/j.taap.2009.08.022openalex-snapshot
In silico toxicology for the pharmaceutical sciences☆
inferred← citeshttps://doi.org/10.1016/s0065-7743(09)04412-1openalex-snapshot
Chapter 12 Advances in the Discovery of Small Molecule JAK3 Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00634openalex-snapshot
Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening
inferred← citeshttps://doi.org/10.1021/acscombsci.6b00010openalex-snapshot
Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.5b00036openalex-snapshot
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
inferred← citeshttps://doi.org/10.1021/acsomega.2c04535openalex-snapshot
Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
inferred← citeshttps://doi.org/10.1093/bib/bbw105openalex-snapshot
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening
inferred← citeshttps://doi.org/10.2174/138620711797537148openalex-snapshot
Integration of Virtual and High Throughput Screening in Lead Discovery Settings
inferred← citeshttps://doi.org/10.3390/molecules30102183openalex-snapshot
Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition Prediction
inferred← citeshttps://doi.org/10.4155/fmc.11.63openalex-snapshot
Software and Resources for Computational Medicinal Chemistry
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.